There are two experimental approaches to treat cancer through tweaking the immune system; both depend on T lymphocytes' having access to tumor. A recent study involving a mouse model demonstrates the importance of accessibility and is thus relevant to both approaches.
No takes yet. Share an insight, caveat, or question.
Steven A. Rosenberg (2004) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: